BiotechTube
Home/Invirsa/Robert Shalwitz, M.D.
RS

Robert Shalwitz, M.D.

CEO

Invirsa

Therapeutic Areas

OphthalmologyRespiratoryMedical Countermeasures

Invirsa Pipeline

DrugIndicationPhase
INV-102Ocular Injury from Sulfur Mustard GasPre-clinical/Phase 2

Leadership Team at Invirsa

RW
Rachael Wingo, MBA
CFO
IS
Isaiah Shalwitz
Program Manager/Biostatistician
View full Invirsa profile